Re-Adjustment of Sweep Gas Flow to the During the Rewarming Period of the Cardiopulmonary Bypass

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAcıbadem Atunizade Hospital

About this trial

The investigators designed this prospective observational study with the theory that alkalosis caused by decreased CO2 solubility due to temperature increase during the rewarming period of the Cardiopulmonary Bypass could be prevented by reducing the sweep gas flow during the rewarming period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients over 18 years of age

Elective CPB surgery

Disqualifiers

Patients undergoing minimally invasive surgery

Patients undergoing robotic cardiac surgery,

Patients undergoing deep hypothermia,

Patients undergoing total circulatory arrest,

Trial population

Patients over 18 years of age scheduled for elective CPB surgery

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Gas Flow Adjustment

    Other intervention

    Decreased gas flow causes PaCO2 to elevate and prevents alkalosis

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: Group 10 interventions
Group B: Group 21 intervention
Group C: Group 31 intervention

Trial outcomes

Primary outcomes

1

Arterial pH lever lower than 7.30

maintaining physiological pH

Time frame
during the cardiopulmonary bypass and postoperative 24th hour

Secondary outcomes

1

rSO2 20% below initial value

observing the rSO2 of brain during rewarming period

Time frame
during the cardiopulmonary bypass

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.